{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:42:33Z","timestamp":1774878153317,"version":"3.50.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100020950","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC-111-2320-B-039-076"],"award-info":[{"award-number":["NSTC-111-2320-B-039-076"]}],"id":[{"id":"10.13039\/501100020950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007404","name":"Clinical Trial Center, China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR-111-141"],"award-info":[{"award-number":["DMR-111-141"]}],"id":[{"id":"10.13039\/100007404","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s12035-023-03779-w","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T20:02:20Z","timestamp":1701288140000},"page":"3819-3835","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Novel Programmed Death Ligand 1-AKT-engineered Mesenchymal Stem Cells Promote Neuroplasticity to Target Stroke Therapy"],"prefix":"10.1007","volume":"61","author":[{"given":"Syuan-Ling","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Wen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long-Bin","family":"Jeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3335-8450","authenticated-orcid":false,"given":"Woei-Cherng","family":"Shyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,29]]},"reference":[{"issue":"7","key":"3779_CR1","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1161\/STROKEAHA.110.612358","volume":"42","author":"O Adeoye","year":"2011","unstructured":"Adeoye O, Hornung R, Khatri P, Kleindorfer D (2011) Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke 42(7):1952\u20131955. https:\/\/doi.org\/10.1161\/STROKEAHA.110.612358","journal-title":"Stroke"},{"key":"3779_CR2","doi-asserted-by":"publisher","unstructured":"Zivin JA (2009) Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the U.S. Food and Drug Administration (FDA). Ann Neurol 66 (1):6\u201310. https:\/\/doi.org\/10.1002\/ana.21750","DOI":"10.1002\/ana.21750"},{"issue":"11","key":"3779_CR3","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa1414792","volume":"372","author":"BC Campbell","year":"2015","unstructured":"Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, Yan B, Dowling RJ et al. (2015) Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 372(11):1009\u20131018. https:\/\/doi.org\/10.1056\/NEJMoa1414792","journal-title":"N Engl J Med"},{"issue":"5","key":"3779_CR4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S1474-4422(09)70061-4","volume":"8","author":"ZG Zhang","year":"2009","unstructured":"Zhang ZG, Chopp M (2009) Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol 8(5):491\u2013500. https:\/\/doi.org\/10.1016\/S1474-4422(09)70061-4","journal-title":"Lancet Neurol"},{"issue":"24","key":"3779_CR5","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1056\/NEJMoa1415061","volume":"372","author":"JL Saver","year":"2015","unstructured":"Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, Albers GW, Cognard C et al. (2015) Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 372(24):2285\u20132295. https:\/\/doi.org\/10.1056\/NEJMoa1415061","journal-title":"N Engl J Med"},{"issue":"7","key":"3779_CR6","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1161\/STROKEAHA.119.027974","volume":"51","author":"I Casetta","year":"2020","unstructured":"Casetta I, Fainardi E, Saia V, Pracucci G, Padroni M, Renieri L, Nencini P, Inzitari D et al. (2020) Endovascular thrombectomy for acute ischemic stroke beyond 6 hours from onset: a real-world experience. Stroke 51(7):2051\u20132057. https:\/\/doi.org\/10.1161\/STROKEAHA.119.027974","journal-title":"Stroke"},{"issue":"5","key":"3779_CR7","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S1474-4422(17)30046-7","volume":"16","author":"DC Hess","year":"2017","unstructured":"Hess DC, Wechsler LR, Clark WM, Savitz SI, Ford GA, Chiu D, Yavagal DR, Uchino K et al. (2017) Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol 16(5):360\u2013368. https:\/\/doi.org\/10.1016\/S1474-4422(17)30046-7","journal-title":"Lancet Neurol"},{"issue":"3","key":"3779_CR8","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1634\/stemcells.2004-0149","volume":"23","author":"S Wislet-Gendebien","year":"2005","unstructured":"Wislet-Gendebien S, Hans G, Leprince P, Rigo JM, Moonen G, Rogister B (2005) Plasticity of cultured mesenchymal stem cells: switch from nestin-positive to excitable neuron-like phenotype. Stem Cells 23(3):392\u2013402. https:\/\/doi.org\/10.1634\/stemcells.2004-0149","journal-title":"Stem Cells"},{"issue":"1","key":"3779_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2011.06.008","volume":"9","author":"AI Caplan","year":"2011","unstructured":"Caplan AI, Correa D (2011) The MSC: an injury drugstore. Cell Stem Cell 9(1):11\u201315. https:\/\/doi.org\/10.1016\/j.stem.2011.06.008","journal-title":"Cell Stem Cell"},{"key":"3779_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/854846","volume":"2012","author":"YR Kuo","year":"2012","unstructured":"Kuo YR, Chen CC, Goto S, Lin PY, Wei FC, Chen CL (2012) Mesenchymal stem cells as immunomodulators in a vascularized composite allotransplantation. Clin Dev Immunol 2012:854846. https:\/\/doi.org\/10.1155\/2012\/854846","journal-title":"Clin Dev Immunol"},{"issue":"12","key":"3779_CR11","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1212\/wnl.56.12.1666","volume":"56","author":"Y Li","year":"2001","unstructured":"Li Y, Chen J, Wang L, Lu M, Chopp M (2001) Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 56(12):1666\u20131672. https:\/\/doi.org\/10.1212\/wnl.56.12.1666","journal-title":"Neurology"},{"issue":"3","key":"3779_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/glia.20126","volume":"49","author":"Y Li","year":"2005","unstructured":"Li Y, Chen J, Zhang CL, Wang L, Lu D, Katakowski M, Gao Q, Shen LH et al. (2005) Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 49(3):407\u2013417. https:\/\/doi.org\/10.1002\/glia.20126","journal-title":"Glia"},{"issue":"6","key":"3779_CR13","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/cpt.927","volume":"103","author":"D Sarmah","year":"2018","unstructured":"Sarmah D, Agrawal V, Rane P, Bhute S, Watanabe M, Kalia K, Ghosh Z, Dave KR et al. (2018) Mesenchymal stem cell therapy in ischemic stroke: a meta-analysis of preclinical studies. Clin Pharmacol Ther 103(6):990\u2013998. https:\/\/doi.org\/10.1002\/cpt.927","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"3779_CR14","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1161\/STROKEAHA.113.003379","volume":"45","author":"SI Savitz","year":"2014","unstructured":"Savitz SI, Cramer SC, Wechsler L, Consortium S (2014) Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials. Stroke 45(2):634\u2013639. https:\/\/doi.org\/10.1161\/STROKEAHA.113.003379","journal-title":"Stroke"},{"issue":"18","key":"3779_CR15","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1182\/blood-2010-12-324038","volume":"117","author":"D Mougiakakos","year":"2011","unstructured":"Mougiakakos D, Jitschin R, Johansson CC, Okita R, Kiessling R, Le Blanc K (2011) The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. Blood 117(18):4826\u20134835. https:\/\/doi.org\/10.1182\/blood-2010-12-324038","journal-title":"Blood"},{"issue":"13","key":"3779_CR16","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1084\/jem.20090847","volume":"206","author":"LM Francisco","year":"2009","unstructured":"Francisco LM, Salinas VH, Brown KE, Vanguri VK, Freeman GJ, Kuchroo VK, Sharpe AH (2009) PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 206(13):3015\u20133029. https:\/\/doi.org\/10.1084\/jem.20090847","journal-title":"J Exp Med"},{"issue":"1","key":"3779_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/ana.20514","volume":"58","author":"A Kroner","year":"2005","unstructured":"Kroner A, Mehling M, Hemmer B, Rieckmann P, Toyka KV, Maurer M, Wiendl H (2005) A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol 58(1):50\u201357. https:\/\/doi.org\/10.1002\/ana.20514","journal-title":"Ann Neurol"},{"issue":"9","key":"3779_CR18","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1161\/STROKEAHA.111.613182","volume":"42","author":"X Ren","year":"2011","unstructured":"Ren X, Akiyoshi K, Vandenbark AA, Hurn PD, Offner H (2011) Programmed death-1 pathway limits central nervous system inflammation and neurologic deficits in murine experimental stroke. Stroke 42(9):2578\u20132583. https:\/\/doi.org\/10.1161\/STROKEAHA.111.613182","journal-title":"Stroke"},{"issue":"3","key":"3779_CR19","doi-asserted-by":"publisher","first-page":"624 e611","DOI":"10.1016\/j.neurobiolaging.2011.03.004","volume":"33","author":"M Saresella","year":"2012","unstructured":"Saresella M, Calabrese E, Marventano I, Piancone F, Gatti A, Farina E, Alberoni M, Clerici M (2012) A potential role for the PD1\/PD-L1 pathway in the neuroinflammation of Alzheimer\u2019s disease. Neurobiol Aging 33(3):624 e611\u2013622. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.03.004","journal-title":"Neurobiol Aging"},{"issue":"6","key":"3779_CR20","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1089\/ten.TEB.2012.0672","volume":"19","author":"J Chen","year":"2013","unstructured":"Chen J, Crawford R, Chen C, Xiao Y (2013) The key regulatory roles of the PI3K\/Akt signaling pathway in the functionalities of mesenchymal stem cells and applications in tissue regeneration. Tissue Eng Part B Rev 19(6):516\u2013528. https:\/\/doi.org\/10.1089\/ten.TEB.2012.0672","journal-title":"Tissue Eng Part B Rev"},{"issue":"3","key":"3779_CR21","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.cardiores.2006.02.016","volume":"70","author":"SY Lim","year":"2006","unstructured":"Lim SY, Kim YS, Ahn Y, Jeong MH, Hong MH, Joo SY, Nam KI, Cho JG et al. (2006) The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model. Cardiovasc Res 70(3):530\u2013542. https:\/\/doi.org\/10.1016\/j.cardiores.2006.02.016","journal-title":"Cardiovasc Res"},{"issue":"6","key":"3779_CR22","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ymthe.2006.05.016","volume":"14","author":"N Noiseux","year":"2006","unstructured":"Noiseux N, Gnecchi M, Lopez-Ilasaca M, Zhang L, Solomon SD, Deb A, Dzau VJ, Pratt RE (2006) Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 14(6):840\u2013850. https:\/\/doi.org\/10.1016\/j.ymthe.2006.05.016","journal-title":"Mol Ther"},{"issue":"7","key":"3779_CR23","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1002\/ijc.30559","volume":"140","author":"SM Wu","year":"2017","unstructured":"Wu SM, Lin SL, Lee KY, Chuang HC, Feng PH, Cheng WL, Liao CJ, Chi HC et al. (2017) Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression. Int J Cancer 140(7):1581\u20131596. https:\/\/doi.org\/10.1002\/ijc.30559","journal-title":"Int J Cancer"},{"issue":"5","key":"3779_CR24","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/S0736-0266(02)00018-9","volume":"20","author":"U Noth","year":"2002","unstructured":"Noth U, Osyczka AM, Tuli R, Hickok NJ, Danielson KG, Tuan RS (2002) Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 20(5):1060\u20131069. https:\/\/doi.org\/10.1016\/S0736-0266(02)00018-9","journal-title":"J Orthop Res"},{"issue":"3","key":"3779_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/(SICI)1097-4636(19981205)42:3<433::AID-JBM13>3.0.CO;2-H","volume":"42","author":"A Laczka-Osyczka","year":"1998","unstructured":"Laczka-Osyczka A, Laczka M, Kasugai S, Ohya K (1998) Behavior of bone marrow cells cultured on three different coatings of gel-derived bioactive glass-ceramics at early stages of cell differentiation. J Biomed Mater Res 42(3):433\u2013442","journal-title":"J Biomed Mater Res"},{"issue":"3","key":"3779_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/14653240600735834","volume":"8","author":"S Urbani","year":"2006","unstructured":"Urbani S, Caporale R, Lombardini L, Bosi A, Saccardi R (2006) Use of CFDA-SE for evaluating the in vitro proliferation pattern of human mesenchymal stem cells. Cytotherapy 8(3):243\u2013253. https:\/\/doi.org\/10.1080\/14653240600735834","journal-title":"Cytotherapy"},{"issue":"2","key":"3779_CR27","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jcyt.2014.10.004","volume":"17","author":"P Nold","year":"2015","unstructured":"Nold P, Hackstein H, Riedlinger T, Kasper C, Neumann A, Mernberger M, Folsch C, Schmitt J et al. (2015) Immunosuppressive capabilities of mesenchymal stromal cells are maintained under hypoxic growth conditions and after gamma irradiation. Cytotherapy 17(2):152\u2013162. https:\/\/doi.org\/10.1016\/j.jcyt.2014.10.004","journal-title":"Cytotherapy"},{"issue":"4","key":"3779_CR28","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1161\/01.STR.17.4.738","volume":"17","author":"ST Chen","year":"1986","unstructured":"Chen ST, Hsu CY, Hogan EL, Maricq H, Balentine JD (1986) A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke 17(4):738\u2013743","journal-title":"Stroke"},{"issue":"13","key":"3779_CR29","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1161\/01.CIR.0000142616.07367.66","volume":"110","author":"WC Shyu","year":"2004","unstructured":"Shyu WC, Lin SZ, Yang HI, Tzeng YS, Pang CY, Yen PS, Li H (2004) Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 110(13):1847\u20131854. https:\/\/doi.org\/10.1161\/01.CIR.0000142616.07367.66","journal-title":"Circulation"},{"issue":"4","key":"3779_CR30","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/ilar.43.4.202","volume":"43","author":"PD Johnson","year":"2002","unstructured":"Johnson PD, Besselsen DG (2002) Practical aspects of experimental design in animal research. ILAR J 43(4):202\u2013206. https:\/\/doi.org\/10.1093\/ilar.43.4.202","journal-title":"ILAR J"},{"issue":"7","key":"3779_CR31","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1172\/JCI34363","volume":"118","author":"WC Shyu","year":"2008","unstructured":"Shyu WC, Liu DD, Lin SZ, Li WW, Su CY, Chang YC, Wang HJ, Wang HW, Tsai CH, Li H (2008) Implantation of olfactory ensheathing cells promotes neuroplasticity in murine models of stroke. J Clin Invest 118(7):2482\u20132495. https:\/\/doi.org\/10.1172\/JCI34363","journal-title":"J Clin Invest"},{"issue":"3","key":"3779_CR32","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/mi.2012.89","volume":"6","author":"CC Bain","year":"2013","unstructured":"Bain CC, Scott CL, Uronen-Hansson H, Gudjonsson S, Jansson O, Grip O, Guilliams M, Malissen B et al. (2013) Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol 6(3):498\u2013510. https:\/\/doi.org\/10.1038\/mi.2012.89","journal-title":"Mucosal Immunol"},{"issue":"3","key":"3779_CR33","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s11011-013-9413-3","volume":"28","author":"S Bodhankar","year":"2013","unstructured":"Bodhankar S, Chen Y, Vandenbark AA, Murphy SJ, Offner H (2013) IL-10-producing B-cells limit CNS inflammation and infarct volume in experimental stroke. Metab Brain Dis 28(3):375\u2013386. https:\/\/doi.org\/10.1007\/s11011-013-9413-3","journal-title":"Metab Brain Dis"},{"issue":"1","key":"3779_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1172\/JCI21655","volume":"114","author":"WH Chou","year":"2004","unstructured":"Chou WH, Choi DS, Zhang H, Mu D, McMahon T, Kharazia VN, Lowell CA, Ferriero DM, Messing RO (2004) Neutrophil protein kinase Cdelta as a mediator of stroke-reperfusion injury. J Clin Invest 114(1):49\u201356. https:\/\/doi.org\/10.1172\/JCI21655","journal-title":"J Clin Invest"},{"issue":"5","key":"3779_CR35","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/sj.jcbfm.9600417","volume":"27","author":"Y Li","year":"2007","unstructured":"Li Y, Lu Z, Keogh CL, Yu SP, Wei L (2007) Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. J Cereb Blood Flow Metab 27(5):1043\u20131054. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600417","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"3779_CR36","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/bpa.12425","volume":"27","author":"MQ Jiang","year":"2017","unstructured":"Jiang MQ, Zhao YY, Cao W, Wei ZZ, Gu X, Wei L, Yu SP (2017) Long-term survival and regeneration of neuronal and vasculature cells inside the core region after ischemic stroke in adult mice. Brain Pathol 27(4):480\u2013498. https:\/\/doi.org\/10.1111\/bpa.12425","journal-title":"Brain Pathol"},{"issue":"Pt 14","key":"3779_CR37","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1242\/jcs.01103","volume":"117","author":"G D'Ippolito","year":"2004","unstructured":"D\u2019Ippolito G, Diabira S, Howard GA, Menei P, Roos BA, Schiller PC (2004) Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 117(Pt 14):2971\u20132981. https:\/\/doi.org\/10.1242\/jcs.01103","journal-title":"J Cell Sci"},{"issue":"7","key":"3779_CR38","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1111\/j.1582-4934.2010.01138.x","volume":"15","author":"M Deschepper","year":"2011","unstructured":"Deschepper M, Oudina K, David B, Myrtil V, Collet C, Bensidhoum M, Logeart-Avramoglou D, Petite H (2011) Survival and function of mesenchymal stem cells (MSCs) depend on glucose to overcome exposure to long-term, severe and continuous hypoxia. J Cell Mol Med 15(7):1505\u20131514. https:\/\/doi.org\/10.1111\/j.1582-4934.2010.01138.x","journal-title":"J Cell Mol Med"},{"issue":"4","key":"3779_CR39","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1747-4949.2008.00222.x","volume":"3","author":"PA McCombe","year":"2008","unstructured":"McCombe PA, Read SJ (2008) Immune and inflammatory responses to stroke: good or bad? Int J Stroke 3(4):254\u2013265. https:\/\/doi.org\/10.1111\/j.1747-4949.2008.00222.x","journal-title":"Int J Stroke"},{"issue":"9","key":"3779_CR40","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/nm912","volume":"9","author":"AA Mangi","year":"2003","unstructured":"Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9(9):1195\u20131201. https:\/\/doi.org\/10.1038\/nm912","journal-title":"Nat Med"},{"issue":"10","key":"3779_CR41","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s13238-011-1097-z","volume":"2","author":"X Liu","year":"2011","unstructured":"Liu X, Duan B, Cheng Z, Jia X, Mao L, Fu H, Che Y, Ou L et al. (2011) SDF-1\/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion. Protein Cell 2(10):845\u2013854. https:\/\/doi.org\/10.1007\/s13238-011-1097-z","journal-title":"Protein Cell"},{"issue":"6","key":"3779_CR42","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1096\/fj.05-5211com","volume":"20","author":"M Gnecchi","year":"2006","unstructured":"Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, Mu H, Melo LG et al. (2006) Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20(6):661\u2013669. https:\/\/doi.org\/10.1096\/fj.05-5211com","journal-title":"FASEB J"},{"key":"3779_CR43","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.6072","volume":"6","author":"W Jin","year":"2018","unstructured":"Jin W, Liang X, Brooks A, Futrega K, Liu X, Doran MR, Simpson MJ, Roberts MS, Wang H (2018) Modelling of the SDF-1\/CXCR4 regulated in vivo homing of therapeutic mesenchymal stem\/stromal cells in mice. PeerJ 6:e6072. https:\/\/doi.org\/10.7717\/peerj.6072","journal-title":"PeerJ"},{"issue":"7","key":"3779_CR44","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1634\/stemcells.2007-0054","volume":"25","author":"AL Ponte","year":"2007","unstructured":"Ponte AL, Marais E, Gallay N, Langonne A, Delorme B, Herault O, Charbord P, Domenech J (2007) The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25(7):1737\u20131745. https:\/\/doi.org\/10.1634\/stemcells.2007-0054","journal-title":"Stem Cells"},{"issue":"7","key":"3779_CR45","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3324\/haematol.10669","volume":"92","author":"M Shi","year":"2007","unstructured":"Shi M, Li J, Liao L, Chen B, Li B, Chen L, Jia H, Zhao RC (2007) Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD\/SCID mice. Haematologica 92(7):897\u2013904. https:\/\/doi.org\/10.3324\/haematol.10669","journal-title":"Haematologica"},{"key":"3779_CR46","doi-asserted-by":"publisher","unstructured":"Fu X, Liu G, Halim A, Ju Y, Luo Q, Song AG (2019) Mesenchymal stem cell migration and tissue repair. Cells 8 (8). https:\/\/doi.org\/10.3390\/cells8080784","DOI":"10.3390\/cells8080784"},{"issue":"1","key":"3779_CR47","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13287-016-0320-5","volume":"7","author":"S Hu","year":"2016","unstructured":"Hu S, Li J, Xu X, Liu A, He H, Xu J, Chen Q, Liu S et al. (2016) The hepatocyte growth factor-expressing character is required for mesenchymal stem cells to protect the lung injured by lipopolysaccharide in vivo. Stem Cell Res Ther 7(1):66. https:\/\/doi.org\/10.1186\/s13287-016-0320-5","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"3779_CR48","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1002\/jcb.25428","volume":"117","author":"A Zhu","year":"2016","unstructured":"Zhu A, Kang N, He L, Li X, Xu X, Zhang H (2016) MiR-221 and miR-26b regulate chemotactic migration of MSCs toward HGF through activation of Akt and FAK. J Cell Biochem 117(6):1370\u20131383. https:\/\/doi.org\/10.1002\/jcb.25428","journal-title":"J Cell Biochem"},{"issue":"13","key":"3779_CR49","doi-asserted-by":"publisher","first-page":"eaay6994","DOI":"10.1126\/sciadv.aay6994","volume":"6","author":"BW Park","year":"2020","unstructured":"Park BW, Jung SH, Das S, Lee SM, Park JH, Kim H, Hwang JW, Lee S et al. (2020) In vivo priming of human mesenchymal stem cells with hepatocyte growth factor-engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair. Sci Adv 6(13):eaay6994. https:\/\/doi.org\/10.1126\/sciadv.aay6994","journal-title":"Sci Adv"},{"issue":"17","key":"3779_CR50","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1089\/scd.2018.0033","volume":"27","author":"K Zhou","year":"2018","unstructured":"Zhou K, Guo S, Tong S, Sun Q, Li F, Zhang X, Qiao Y, Liang G (2018) Immunosuppression of human adipose-derived stem cells on T cell subsets via the reduction of NF-kappaB activation mediated by PD-L1\/PD-1 and Gal-9\/TIM-3 pathways. Stem Cells Dev 27(17):1191\u20131202. https:\/\/doi.org\/10.1089\/scd.2018.0033","journal-title":"Stem Cells Dev"},{"issue":"4","key":"3779_CR51","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3892\/etm.2017.4131","volume":"13","author":"S Ma","year":"2017","unstructured":"Ma S, Chen X, Wang L, Wei Y, Ni Y, Chu Y, Liu Y, Zhu H et al. (2017) Repairing effects of ICAM-1-expressing mesenchymal stem cells in mice with autoimmune thyroiditis. Exp Ther Med 13(4):1295\u20131302. https:\/\/doi.org\/10.3892\/etm.2017.4131","journal-title":"Exp Ther Med"},{"issue":"8","key":"3779_CR52","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1161\/STROKEAHA.117.016705","volume":"48","author":"R Han","year":"2017","unstructured":"Han R, Luo J, Shi Y, Yao Y, Hao J (2017) PD-L1 (Programmed Death Ligand 1) protects against experimental intracerebral hemorrhage-induced brain injury. Stroke 48(8):2255\u20132262. https:\/\/doi.org\/10.1161\/STROKEAHA.117.016705","journal-title":"Stroke"},{"issue":"10","key":"3779_CR53","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1161\/STROKEAHA.115.010592","volume":"46","author":"S Bodhankar","year":"2015","unstructured":"Bodhankar S, Chen Y, Lapato A, Dotson AL, Wang J, Vandenbark AA, Saugstad JA, Offner H (2015) PD-L1 monoclonal antibody treats ischemic stroke by controlling central nervous system inflammation. Stroke 46(10):2926\u20132934. https:\/\/doi.org\/10.1161\/STROKEAHA.115.010592","journal-title":"Stroke"},{"issue":"4","key":"3779_CR54","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1172\/jci38831","volume":"119","author":"U Modlich","year":"2009","unstructured":"Modlich U, Baum C (2009) Preventing and exploiting the oncogenic potential of integrating gene vectors. J Clin Invest 119(4):755\u2013758. https:\/\/doi.org\/10.1172\/jci38831","journal-title":"J Clin Invest"},{"issue":"5","key":"3779_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000491","volume":"5","author":"UP Dave","year":"2009","unstructured":"Dave UP, Akagi K, Tripathi R, Cleveland SM, Thompson MA, Yi M et al. (2009) Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy. PLoS Genet 5(5):e1000491. https:\/\/doi.org\/10.1371\/journal.pgen.1000491","journal-title":"PLoS Genet"},{"issue":"3","key":"3779_CR56","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.cell.2005.07.013","volume":"122","author":"S Ding","year":"2005","unstructured":"Ding S, Wu X, Li G, Han M, Zhuang Y, Xu T (2005) Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. Cell 122(3):473\u2013483. https:\/\/doi.org\/10.1016\/j.cell.2005.07.013","journal-title":"Cell"},{"issue":"25","key":"3779_CR57","doi-asserted-by":"publisher","first-page":"E2279","DOI":"10.1073\/pnas.1305987110","volume":"110","author":"X Li","year":"2013","unstructured":"Li X, Burnight ER, Cooney AL, Malani N, Brady T, Sander JD, Staber J, Wheelan SJ et al. (2013) piggyBac transposase tools for genome engineering. Proc Natl Acad Sci U S A 110(25):E2279-2287. https:\/\/doi.org\/10.1073\/pnas.1305987110","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"3779_CR58","doi-asserted-by":"publisher","first-page":"e1012","DOI":"10.1212\/WNL.0000000000011440","volume":"96","author":"JW Chung","year":"2021","unstructured":"Chung JW, Chang WH, Bang OY, Moon GJ, Kim SJ, Kim SK, Lee JS et al. (2021) Efficacy and safety of intravenous mesenchymal stem cells for ischemic stroke. Neurology 96(7):e1012\u2013e1023. https:\/\/doi.org\/10.1212\/WNL.0000000000011440","journal-title":"Neurology"},{"issue":"5","key":"3779_CR59","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1161\/STROKEAHA.117.018288","volume":"49","author":"R Guzman","year":"2018","unstructured":"Guzman R, Janowski M, Walczak P (2018) Intra-arterial delivery of cell therapies for stroke. Stroke 49(5):1075\u20131082. https:\/\/doi.org\/10.1161\/STROKEAHA.117.018288","journal-title":"Stroke"},{"issue":"11","key":"3779_CR60","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1002\/stem.2087","volume":"33","author":"S Wang","year":"2015","unstructured":"Wang S, Guo L, Ge J, Yu L, Cai T, Tian R, Jiang Y, Zhao R et al. (2015) Excess integrins cause lung entrapment of mesenchymal stem cells. Stem Cells 33(11):3315\u20133326. https:\/\/doi.org\/10.1002\/stem.2087","journal-title":"Stem Cells"},{"issue":"5","key":"3779_CR61","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/scd.2008.0253","volume":"18","author":"UM Fischer","year":"2009","unstructured":"Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, Laine GA, Cox CS Jr (2009) Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 18(5):683\u2013692. https:\/\/doi.org\/10.1089\/scd.2008.0253","journal-title":"Stem Cells Dev"},{"key":"3779_CR62","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1742-2094-10-115","volume":"10","author":"NV Gronberg","year":"2013","unstructured":"Gronberg NV, Johansen FF, Kristiansen U, Hasseldam H (2013) Leukocyte infiltration in experimental stroke. J Neuroinflammation 10:115. https:\/\/doi.org\/10.1186\/1742-2094-10-115","journal-title":"J Neuroinflammation"},{"issue":"6","key":"3779_CR63","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1161\/STROKEAHA.118.020203","volume":"49","author":"WN Jin","year":"2018","unstructured":"Jin WN, Gonzales R, Feng Y, Wood K, Chai Z, Dong JF, La Cava A, Shi FD et al. (2018) Brain ischemia induces diversified neuroantigen-specific T-Cell responses that exacerbate brain injury. Stroke 49(6):1471\u20131478. https:\/\/doi.org\/10.1161\/STROKEAHA.118.020203","journal-title":"Stroke"},{"issue":"1","key":"3779_CR64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12974-020-02057-z","volume":"18","author":"TY Lei","year":"2021","unstructured":"Lei TY, Ye YZ, Zhu XQ, Smerin D, Gu LJ, Xiong XX, Zhang HF, Jian ZH (2021) The immune response of T cells and therapeutic targets related to regulating the levels of T helper cells after ischaemic stroke. J Neuroinflammation 18(1):25. https:\/\/doi.org\/10.1186\/s12974-020-02057-z","journal-title":"J Neuroinflammation"},{"issue":"7","key":"3779_CR65","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41419-019-1716-9","volume":"10","author":"AQ Chen","year":"2019","unstructured":"Chen AQ, Fang Z, Chen XL, Yang S, Zhou YF, Mao L, Xia YP, Jin HJ et al. (2019) Microglia-derived TNF-alpha mediates endothelial necroptosis aggravating blood brain-barrier disruption after ischemic stroke. Cell Death Dis 10(7):487. https:\/\/doi.org\/10.1038\/s41419-019-1716-9","journal-title":"Cell Death Dis"},{"key":"3779_CR66","doi-asserted-by":"publisher","unstructured":"Cai W, Shi L, Zhao J, Xu F, Dufort C, Ye Q, Yang T, Dai X et al. (2022) Neuroprotection against ischemic stroke requires a specific class of early responder T cells in mice. J Clin Invest 132 (15). https:\/\/doi.org\/10.1172\/JCI157678","DOI":"10.1172\/JCI157678"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03779-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03779-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03779-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T13:16:27Z","timestamp":1720617387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03779-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,29]]},"references-count":66,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["3779"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03779-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,29]]},"assertion":[{"value":"9 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The collected human umbilical cord tissues were approved by the Institutional Review Board (IRB) of the China Medical University Hospital, Taichung.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors consent to the publication of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}